U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07833527) titled 'Effect of Proso Millet-Based Bread on Postprandial Glycemic Response in Adults With Type 2 Diabetes' on Sept. 16.
Brief Summary: This randomized, double-blind, crossover clinical study aims to evaluate the acute effect of proso millet-based bread on postprandial glycemic response in adults with type 2 diabetes. A total of 52 participants are planned to be enrolled.
Each participant will attend two test sessions and will consume proso millet-based bread in one session and white wheat bread in the other. The order of the test breads will be randomized, and the two sessions will be separated by a one-week washout period. Each bread p...